Whitebox Advisors’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-50,000
Closed -$29K 1020
2021
Q3
$29K Hold
50,000
﹤0.01% 544
2021
Q2
$36K Buy
+50,000
New +$28.3K ﹤0.01% 451

Other funds holding EQHA.WS

Whitebox Advisors's EQHA.WS Position: Q4 2022 in Review

Whitebox Advisors sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 46,000 shares — an estimated $4K sold.

Whitebox Advisors first reported a position in EQHA.WS in Q4 2021 and held it in 4 quarters. The position peaked at $26K in Q4 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Whitebox Advisors reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Whitebox Advisors sold 46,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $4K.
  • Whitebox Advisors first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 4 quarters.
  • Whitebox Advisors's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $26K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Whitebox Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.